Keywords
How to Cite
Abstract
El cáncer gástrico (CG) continúa siendo un problema de salud pública en Colombia. Es el tercer cáncer más diagnosticado en hombres, con 2760 casos reportados para el 2014, con una tasa ajustada de 18,5 casos por cada 100.000, esto en comparación con la tasa de 7,4 casos por cada 100.000 habitantes en Estados Unidos. La incidencia del CG en los países desarrollados viene en descenso, pues en los Estados Unidos ha disminuido en un 1,5 % cada año en los últimos diez años y ello se ha asociado a una mejora en las condiciones socioeconómicas [1].
National Cancer Institute. SEER Stat Fact Sheets: Stomach Cancer [internet]. Disponible en: http://seer.cancer.gov/statfacts/html/stomach.html
Henao F, Rosero G, García C, Lanza A. Manejo quirúrgico del cáncer gástrico: 6 años de experiencia en un hospital de IV nivel. Documento procedente del Congreso Nacional de Cirugía; agosto 2016; Bogotá, Colombia.
de Vries AC, Kuipers EJ. Epidemiology of premalignant gastric lesions: implications for the development of screening and surveillance strategies. Helicobacter. 2007;12(suppl 2):22-31.
Fuccio L, Zagari RM, Eusebi LH, Laterza L, Cennamo V, Ceroni L, et al. Meta-analysis: can Helicobacter pylori eradication treatment reduce the risk for gastric cancer? Ann Intern Med. 2009;151:121-8.
The Research Group for Population-based Cancer Registration in Japan. Annual reports 1997-2003, 1998-2004. Osaka: Research Group for Population-based Cancer Registration; 2005.
Choi KS, Jun JK, Suh M, Park B, Noh DK, Song SH, et al. Effect of endoscopy screening on stage at gastric cancer diagnosis: Results of the National Cancer Screening Programme in Korea. Br J Cancer. 2015;112:608-12. doi:10.1038/bjc.2014.608
Shulei Z, Zhang X, Wang J. Endoscopic resection versus surgery for early gastric cancer and precancerous lesions: a meta-analysis. Springerplus. 2016;5(1):678.
Songun I, Putter H, Kranenbarg EM, Sasako M, van de Velde CJ. Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial. Lancet Oncol. 2010;11(5):439-49. doi: 10.1016/S1470-2045(10)70070-X
Cunningham D, Allum WH, Stenning SP, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med. 2006; 355:11.
Macdonald JS, Smalley SR, Benedetti J, et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med. 2001;345:725.
Schulte N, Matthias P. Härtel E. Gastric cancer: new drugs-new strategies. Gastrointest Tumors. 2014;1:180-94.
This journal is registered under a Creative Commons Attribution 4.0 International Public License. Thus, this work may be reproduced, distributed, and publicly shared in digital format, as long as the names of the authors and Pontificia Universidad Javeriana are acknowledged. Others are allowed to quote, adapt, transform, auto-archive, republish, and create based on this material, for any purpose (even commercial ones), provided the authorship is duly acknowledged, a link to the original work is provided, and it is specified if changes have been made. Pontificia Universidad Javeriana does not hold the rights of published works and the authors are solely responsible for the contents of their works; they keep the moral, intellectual, privacy, and publicity rights.
Approving the intervention of the work (review, copy-editing, translation, layout) and the following outreach, are granted through an use license and not through an assignment of rights. This means the journal and Pontificia Universidad Javeriana cannot be held responsible for any ethical malpractice by the authors. As a consequence of the protection granted by the use license, the journal is not required to publish recantations or modify information already published, unless the errata stems from the editorial management process. Publishing contents in this journal does not generate royalties for contributors.